Novonesis

Also known as Novo Enzymes A/S, Novozymes A/S, Novonesis A/S

Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.

Key facts

Company.name: Novozymes A/S
Company.trading_name: Novozymes
Company.logo: Novozymes_logo.svg
Company.image: Novozymes - hovedbygning Bagsværd.jpg
Company.logo_size: 225px
Company.type: Aktieselskab
Company.parent: Novo Holdings A/S
Company.fate: Merged with Chr. Hansen
Company.successor: Novonesis
Company.location: Bagsværd, Denmark
Company.industry: Biotechnology
Company.products: Enzymes, microorganisms, biopharmaceutical ingredients

~3 min read

Article

4 sections

Contents

History
Ownership
References
External links

Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange.